Elevated serum aminoterminal procollagen type-III-peptide parallels collagen accumulation in rats with secondary biliary fibrosis

Journal of Hepatology

Volumn 25, Issue 1, 1996, Pages 79-84

  Gerling, Burkard ^b   Becker, Michael ^a   Waldschmidt, Jürgen ^b   Rehmann, Martina ^b   Schuppan, Detlef ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

Aminoterminal procollagen III peptide; Bile duct occlusion; Cholestasis; Hydroxyproline; Liver fibrosis; Rat

Indexed keywords

PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE DUCT OBSTRUCTION; BILE FLOW; CHOLESTASIS; CHRONIC LIVER DISEASE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FEMALE; FIBROGENESIS; FIBROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

EID: 0030199310     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80331-X     Document Type: Article

References (30)

1. Ruwart MJ, Wilkinson KF, Rush BD, Vidmar TJ, Peters KM, Henley KS, Appelman HD, Kim KY, Schuppan D, Hahn EG. The integrated value of serum procollagen III peptide over time predicts hepatic hydroxyproline content and stainable collagen in a model of dietary cirrhosis in the rat. Hepatology. 10:1989;801-806.
2. Colombo M, Annoni G, Donato MF, Conte D, Martines D, Zaramella MG, Bianchi PA, Pipeono A, Tribelli C. Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: its relationship to hepatic fibrosis, activity of the disease and iron overload. Hepatology. 3:1985;475-479.
3. Frei A, Zimmermann A, Weigand K. The N terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease. Hepatology. 5:1984;830-834.
4. Abdi W, Millan JC, Mezey E. Sampling variability in percutaneous liver biopsy. Arch Intern Med. 139:1979;667-669.
5. Schuppan D. Connective tissue polypeptides in serum as parameters to monitor antifibrotic treatment in hepatic fibrogenesis. J Hepatol. 13:(Suppl 3):1991;17-25.
6. Schuppan D, Stölzel U, Oesterling C, Somasundaram R. Serum assays for liver fibrosis. J Hepatol. 22:(Suppl 2):1995;82-88.
7. Risteli L, Risteli J. Noninvasive methods for detection of organ fibrosis. Rojkind M. Focus on Connective Tissue in Health and Disease. 1990;61-98 CRC Press, Boca Raton.
8. Annoni G, Cargnel A, Colombo M, Hahn EG. Persistent elevation of the aminoterminal peptide of procollagen type III in serum of patients with acute viral hepatitis distinguishes chronic active hepatitis from resolving or chronic persistent hepatitis. J Hepatol. 2:1986;379-388.
9. Babbs C, Smith A, Hunt LP, Rowan B, Haboubi NY, Warnes TW. Type III procollagen peptide: a marker of disease activity and prognosis in primary biliary cirrhosis. Lancet. i:1988;1021-1024.
10. Bentsen KD, Horn T, Risteli J, Risteli L, Engström-Laurent A, Hørslev-Petersen K, Lorenz I. Serum aminoterminal procollagen peptide and 7S domain of type IV collagen in patients with alcohol abuse. Liver. 7:1987;339-346.
11. Bentsen KD, Hørslev-Petersen K, Junker P, Juhl E, Lorenzen I. Serum amino-terminal procollagen type III peptide in acute viral hepatitis. A long term follow-up study. Liver. 7:1987;96-105.
12. Beukers R, van Zanthen RA, Schalm SW. Serial determination of type III procollagen amino peptide serum levels in patients with histologically progressive and non-progressive primary biliary cirrhosis. J Hepatol. 14:1992;22-29.
13. El-Mohandes M, Hassanein H, El-Batrawy N, Voss B, Gerlach U. Serum concentration of N-terminal procollagen peptide of collagen type III in schistosomal liver fibrosis. Exp Mol Pathol. 46:1986;383-390.
14. Erikson S, Zettevall O. The N-terminal propeptide of collagen type III in serum as a prognostic indicator in primary biliary cirrhosis. J Hepatol. 2:1986;370-378.
15. Galambos MR, Collins DC, Galambos JT. A radioimmunoassay procedure for type III procollagen: its use for detection of hepatic fibrosis. Hepatology. 1:1985;38-42.
16. McCullough AJ, Stassen WN, Wiesner RH, Czaja AJ. Serial determination of the aminoterminal peptide of type III procollagen in severe chronic active hepatitis. J Lab Clin Med. 1:1987;55-61.
17. McCullough AJ, Strassen WN, Wiesner RH, Czaja AJ. Serum type III procollagen peptide concentrations in severe chronic active hepatitis: relationship to cirrhosis and disease activity. Hepatology. 7:1987;49-54.
18. Niemelä O, Risteli L, Sotaniemi E, Stenbäck F, Risteli J. Serum basement-membrane and type III procollagen - related antigens in primary biliary cirrhosis. J Hepatol. 6:1988;307-314.
19. Sato S, Tashihiko N, Womer TM, Lieber CS. Liver fibrosis in alcoholics. Detection by fab radioimmunoassay of serum procollagen III peptides. JAMA. 256:1986;1471-1473.
20. Surrenti C, Casini A, Milani S, Ambu S, Cecatelli P, D'Àgata A. Is determination of serum N-terminal procollagen type III peptide (sPIIIP) a marker of hepatic fibrosis? Dig Dis Sci. 7:1987;705-709.
21. Torres-Salinas M, Pares A, Caballeria J, Jimenez W, Heredia D, Bruguera M, Rodes I. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis. Gastroenterology. 90:1986;1241-1246.
22. Trivedi P, Cheeseman P, Porman B, Hegarty J, Mowat AP. Variation in serum type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis. Eur J Clin Invest. 15:1985;69-74.
23. Trivedi P, Risteli J, Risteli L, Tanner MS, Bhave S, Pandit AN, Mowat A.P. Serum type III procollagen and basement membrane proteins as non-invasive markers of hepatic pathology in Indian childhood cirrhosis. Hepatology. 6:1987;1249-1253.
24. Weigand K, Zaugg PY, Frei A, Zimmermann A. Long-term follow-up of serum N-terminal propeptide of collagen type III levels in patients with chronic liver disease. Hepatology. 4:1984;835-838.
25. Schuppan D, Dumont JM, Kim KY, Hennings G, Hahn EG. Serum concentration of the aminoterminal procollagen type III peptide in the rat reflects early formation of connective tissue in experimental liver cirrhosis. J Hepatol. 3:1986;27-37.
26. Hayasaka A, Koch J, Schuppan D, Maddrey WC, Hahn EG. The serum concentrations of the aminoterminal propeptide of procollagen type III and the hepatic content of mRNA for the alpha 1 chain of procollagen type III in carbon tetrachloride-induced rat liver fibrogenesis. J Hepatol. 13:1991;328-338.
27. Jamal JS, Finelli VN, Que Hee SS. A simple method to determine nanogram levels of hydroxyproline in biological tissues. Anal Biochem. 112:1981;70-75.
28. Rohde H, Vargas L, Hahn EG, Kalbfleisch H, Bruguera M, Timpl R. Radioimmunoassay for type III procollagen peptide and its application for human liver disease. Eur J Clin Invest. 9:1979;451-459.
29. Schweizer P, Schubert G.E, Reifferscheid P. Das unterschiedliche morphologische Bild der Leber des Schweins und der Ratte nach Gallengangsverschluß Z Kinderchir. 14:1974;61-74.
30. Ballardini G, Faccani A, Bianchi FB, Famlani M, Patrono D, Capelli M, Pisi E. Steroid treatment lowers hepatic fibroplasia, as explored by serum aminoterminal procollagen III peptide, in chronic liver disease. Liver. 4:1984;348-352.